Literature DB >> 25139016

Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.

Sara Passos1, Lucas P Carvalho2, Rúbia S Costa3, Taís M Campos3, Fernanda O Novais4, Andréa Magalhães3, Paulo R L Machado1, Daniel Beiting4, David Mosser5, Edgar M Carvalho1, Phillip Scott4.   

Abstract

Ulcer development in patients with cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is associated with high levels of tumor necrosis factor (TNF). We found that early after infection, before ulcer development, the frequency of CD16(+) (both intermediate [CD14(+)CD16(+)] and nonclassical [CD14(dim)CD16(+)]) monocytes was increased in the peripheral blood of patients with L. braziliensis, compared with uninfected controls. These results suggest that CD16(+) monocytes might promote disease. Also, we found that intermediate monocytes expressed CCR2 and that increased levels of CCL2 protein were present in lesions from patients, suggesting that intermediate monocytes are more likely than nonclassical monocytes to migrate to the lesion site. Finally, we found that the intermediate monocytes produced TNF. Our results show that intermediate monocytes are increased in frequency soon after infection; express CCR2, which would promote their migration into the lesions; and, owing to their production of TNF, can enhance the inflammatory response.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  L. braziliensis; immune response; monocytes

Mesh:

Substances:

Year:  2014        PMID: 25139016      PMCID: PMC4334833          DOI: 10.1093/infdis/jiu439

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

1.  Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

Authors:  Daniela R Faria; Kenneth J Gollob; José Barbosa; Albert Schriefer; Paulo R L Machado; Hélio Lessa; Lucas P Carvalho; Marco Aurélio Romano-Silva; Amélia R de Jesus; Edgar M Carvalho; Walderez O Dutra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

Authors:  Kai-Uwe Belge; Farshid Dayyani; Alexia Horelt; Maciej Siedlar; Marion Frankenberger; Bernhard Frankenberger; Terje Espevik; Löms Ziegler-Heitbrock
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

3.  Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release.

Authors:  Subhadeep Chakrabarti; Jennifer M Zee; Kamala D Patel
Journal:  J Leukoc Biol       Date:  2005-11-07       Impact factor: 4.962

4.  Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.

Authors:  G Sadeghian; M A Nilforoushzadeh
Journal:  Int J Dermatol       Date:  2006-07       Impact factor: 2.736

5.  Cytokine profile and pathology in human leishmaniasis.

Authors:  A Ribeiro-de-Jesus; R P Almeida; H Lessa; O Bacellar; E M Carvalho
Journal:  Braz J Med Biol Res       Date:  1998-01       Impact factor: 2.590

6.  Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections.

Authors:  Amelia Ribeiro de Jesus; Tânia Luna; Roque Pacheco de Almeida; Paulo Roberto Lima Machado; Edgar M Carvalho
Journal:  Int Immunopharmacol       Date:  2008-04-28       Impact factor: 4.932

7.  Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis.

Authors:  M Frankenberger; T Sternsdorf; H Pechumer; A Pforte; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

8.  Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection.

Authors:  Ricardo Goncalves; Xia Zhang; Heather Cohen; Alain Debrabant; David M Mosser
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

9.  Protective and pathologic immune responses in human tegumentary leishmaniasis.

Authors:  Lucas P Carvalho; Sara Passos; Albert Schriefer; Edgar M Carvalho
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

10.  Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis.

Authors:  Fernanda O Novais; Lucas P Carvalho; Joel W Graff; Daniel P Beiting; Gordon Ruthel; David S Roos; Michael R Betts; Michael H Goldschmidt; Mary E Wilson; Camila I de Oliveira; Phillip Scott
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

View more
  35 in total

1.  A Potential Role for Mononuclear Phagocytes in Cutaneous Ulcer Development in Human Immunodeficiency Virus-Leishmania braziliensis Coinfection.

Authors:  Luiz H Guimarães; Maíra Saldanha; Taís Menezes; Lis Moreno; Alex Torres; Rúbia Costa; Sara Passos; Roberto Badaró; Sérgio Arruda; Lucas P Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

2.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

3.  Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis.

Authors:  Neetu Singh; Rajiv Kumar; Shashi Bhushan Chauhan; Christian Engwerda; Shyam Sundar
Journal:  J Infect Dis       Date:  2018-08-24       Impact factor: 5.226

4.  Leishmania infantum Infection of Primary Human Myeloid Cells.

Authors:  Morgane Picard; Calaiselvy Soundaramourty; Ricardo Silvestre; Jérôme Estaquier; Sónia André
Journal:  Microorganisms       Date:  2022-06-17

5.  Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Authors:  Rúbia S Costa; Lucas P Carvalho; Taís M Campos; Andréa S Magalhães; Sara T Passos; Albert Schriefer; Juliana A Silva; Ednaldo Lago; Camilla S Paixão; Paulo Machado; Phillip Scott; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

6.  Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.

Authors:  Taís M Campos; Fernanda O Novais; Maíra Saldanha; Rúbia Costa; Morgana Lordelo; Daniela Celestino; Camilla Sampaio; Natália Tavares; Sérgio Arruda; Paulo Machado; Cláudia Brodskyn; Phillip Scott; Edgar M Carvalho; Lucas P Carvalho
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226

7.  IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis.

Authors:  Daniela Santos; Taís M Campos; Maíra Saldanha; Sergio C Oliveira; Mauricio Nascimento; Dario S Zamboni; Paulo R Machado; Sérgio Arruda; Phillip Scott; Edgar M Carvalho; Lucas P Carvalho
Journal:  J Invest Dermatol       Date:  2017-12-12       Impact factor: 8.551

8.  The Leishmania antigen-specific pro-inflammatory response in cutaneous leishmaniasis is linked to disease progression but not to the therapeutic failure of pentavalent antimonials.

Authors:  Mônica Franca; Luiz H Guimarães; Maurício T Nascimento; Paulo N Rocha; Lucas P Carvalho
Journal:  Microbes Infect       Date:  2021-07-21       Impact factor: 2.700

9.  A curated compendium of monocyte transcriptome datasets of relevance to human monocyte immunobiology research.

Authors:  Darawan Rinchai; Sabri Boughorbel; Scott Presnell; Charlie Quinn; Damien Chaussabel
Journal:  F1000Res       Date:  2016-04-25

10.  The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis.

Authors:  Pedro Paulo Carneiro; Jacilara Conceição; Michael Macedo; Viviane Magalhães; Edgar M Carvalho; Olivia Bacellar
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.